Рациональная фармакотерапия в кардиологии (Dec 2015)

STATINS AND MYOPATHY: MOLECULAR MECHANISMS

  • O. M. Drapkina,
  • E. M. Chernova,
  • O. N. Korneeva

DOI
https://doi.org/10.20996/1819-6446-2012-8-3-469-473
Journal volume & issue
Vol. 8, no. 3
pp. 469 – 473

Abstract

Read online

The safety of statin therapy is considered. In particular the reasons of a complication such as myopathy are discussed in detail. The molecular mechanisms of statin myopathy , as well as its risk factors are presented. The role of coenzyme Q10 in the myopathy development and coenzyme Q10 application for the prevention of this complication are considered.

Keywords